The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LungTS: A new gene expression signature for prediction of response to checkpoint inhibitors in non-small cell lung cancer.
 
Pedro De Marchi
Honoraria - Sanofi
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Merck; Merck Sharp & Dohme; Novartis; Roche; Takeda
Research Funding - Amgen; AstraZeneca; Merck Sharp & Dohme; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
 
Leticia Ferro Leal
Research Funding - AstraZeneca
 
Luciane Sussuchi da Silva
No Relationships to Disclose
 
Rodrigo de Oliveira Cavagna
No Relationships to Disclose
 
Flavio Augusto Ferreira da Silva
No Relationships to Disclose
 
Vinicius Duval da Silva
No Relationships to Disclose
 
Eduardo CA da Silva
No Relationships to Disclose
 
Augusto Obuti Saito
No Relationships to Disclose
 
Cristina Aguado
No Relationships to Disclose
 
Jill Bracht
No Relationships to Disclose
 
Maria Gonzalez-Cao
No Relationships to Disclose
 
Ana Giménez-Capitán
No Relationships to Disclose
 
Carlos Pedraz
No Relationships to Disclose
 
Daniella Dias Silva Sá
No Relationships to Disclose
 
Miguel Angel Molina Vila
Employment - Pangaea Oncology
Research Funding - AstraZeneca (Inst); In3Bio (Inst); Merck Serono (Inst)
 
Vladmir Claudio Cordeiro De Lima
Consulting or Advisory Role - Amgen; AstraZeneca; BMS Brazil; Daiichi-Sankyo; Janssen; Lilly; MSD; Pfizer
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; BMS Brazil; Lilly; MSD; Novartis
Research Funding - BMS (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BMS Brazil; Boehringer Ingelheim; MSD
 
Rui Manuel Reis
Research Funding - MSD Oncology